Summary Cytogenetic analysis of short-term cultures from seven pulmonary hamartomas revealed an abnormal karyotype in six of them. The most characteristic aberration was an exchange of material between 6p21 and 14q24, found in three tumours. Abnormalities of either 6p or 14q were seen in another two hamartomas. Other regions that were rearranged more than once were 12q (three times) and 17p (twice), sometimes in exchange with 6p or 14q and giving rise to complex derivative chromosomes. Only one tumour had aberrations that did not involve 6p, 12q, 14q, or 17p. These results -together with the data on three previously reported pulmonary hamartomas, two of which also had t(6;14) -show that recombinations between 6p2l and 14q24 are common, and hence probably pathogenetically important. The data support the view that these tumours are genuine neoplasms rather than developmental anomalies. The coexistence of a common 14q24 breakpoint in uterine leiomyomas and pulmonary hamartomas indicates that a gene important in the genesis of both tumours exists in this band.
Hamartomas are the most common tumourous lesions of the lung, occurring in approximately 0.3% of the general population (Koutras et al., 1971) . They are usually peripherally situated, grow slowly, and are invariably benign. The tumours are well circumscribed and consist of focal overgrowths of tissues normally present in the lung, such as cartilage, smooth muscle, other connective tissue elements, and respiratory tract epithelium (Koss, 1990) . The relative proportions of these components may vary from case to case, which has led to a quantitative classification of hamartomas into chondromatous and leiomyomatous (WHO, 1982) . Mostly, the cartilaginous tissue predominates.
The pathogenetic nature of hamartomas has been a muchcontended issue. Are they developmental anomalies or genuine neoplasms? The former view long prevailed, but arguments for a neoplastic origin seem to have gained in strength in later decades (Butler & Kleinerman, 1969; Bateson, 1973; Stone & Churg, 1976; Perez-Atayde & Seiler, 1984) . If hamartomas are neoplastic, then the next question must be whether they are truly biphasic tumours -i.e., both the epithelial and mesenchymal components are part of the neoplastic parenchyma -or monophasic, in which case either the epithelium or the tumour's connective tissue is the essential element driving the neoplastic growth. The concept of lung hamartomas as primarily mesenchymal tumours has latterly come to dominate, and whatever non-mesenchymal components they contain are seen as stemming from preexisting airway epithelium entrapped as clefts when the tumour grows (Bateson, 1973; Inze & Lui, 1977; Tomashefski, 1982; Perez-Atayde & Seiler, 1984) .
It is now widely accepted that neoplastic transformation is brought about by somatic cell mutations occurring in a limited set of genes that are crucial in proliferation and differentiation. Often the relevant mutations are seen at the cytogenetic level, and more and more characteristic abnormalities have been described also in solid tumours . In this report we describe the detection of acquired, specific, clonal chromosome aberrations in a series of hamartomas of the lung. This argues strongly in favour of a neoplastic genesis of such tumours. The nature of the chromosomal anomalies indicates that pulmonary hamartomas and uterine leiomyomas are tumourigenetically related.
Materials and methods
A brief summary of the clinical characteristics of the seven cases is given in Table I . In all cases, the histological picture was one of mature cartilage mixed with smooth muscle fibres and occasional epithelial clefts (Figure 1 ). The cartilage component dominated and so the diagnosis was cartilaginous pulmonary hamartoma. Cases 1 and 3-7 were processed in Lund, case 2 in Odense. Fresh tumour specimens were minced with scissors and enzymatically disaggregated in collagenase II (1 400 U ml-') for 2-5 h. The resulting cell suspension was in cases I and 3-7 plated on glass chamber slides in RPMI 1640 medium with HEPES buffer, supplemented with 10% foetal calf serum, L-glutamine (0.24mg ml-'), insulin (5 fig ml1 ' ), epithelial growth factor (1 ng ml-'), hydrocortisone (0.36 ig ml 1), streptomycin (200 .tg ml-'), and penicillin (100 IU ml-'). The cultures were harvested in situ after 3-10 days by Colcemid (0.02 jLg ml-') exposure for 4-5 h followed by hypotonic treatment in 0.3% NaCl and gradual fixations in methanol:acetic acid (3:1).
In case 2, short-term cultures were initiated in plastic flasks (Primaria-modified surface, Falcon) in Dulbecco's Modified Eagle Medium: Ham's Nutrient Mixture F12 (1:1) with HEPES buffer supplemented with foetal calf serum (20%), L-glutamine (0.44 mg ml-'), penicillin (100 IU ml-'), streptomycin (100 ig ml-'), epidermal growth factor (20 ng ml-'), hydrocortisone (0.5jigrml-'), fetuin (20jigm -'), phosphoethanolamine (0.1 mM), cholera toxin (100 ng ml-'), ascorbic acid (10 ig ml-'), dibutyl cyclic acid AMP (1O nM), fibronectin (100 ng ml-'), triiodothyronine (10 nM), trace element mix (Gibco) (1 jil ml-'), and 1% ITS+ (Collaborative Research) giving final concentrations of 6.25jigrml-' insulin, 6.25ng additional inversion in the derivative chromosome 14 had also occurred).
Discussion
Although some examples exist to the contrary (Johansson et al., 1993) , in general the rule holds that whenever acquired, clonal chromosome abnormalities are found, this means that the investigated disease process is neoplastic (Heim & Mitelman, 1987; Sandberg, 1990) . Clonal chromosome aberrations have previously been described in three pulmonary hamartomas (Fletcher et al., 1991; Johansson et al., 1992) . With the series of tumours we describe now, it must be accepted as a fact that most hamartomas of the lung are characterized by abnormal karyotypes. This strongly supports the view that they are genuine neoplasms, not just focal overgrowths of disorganized but otherwise normal lung tissue. Not only do pulmonary hamartomas have clonal chromosomal abnormalities, but the aberrations they contain are nonrandomly distributed throughout the genome. Various recombinations between 6p and 14q, sometimes leading to a der(6)t(6;14) (p21;q24) and sometimes to a der(14)t(6;14) (p21;q24), were found in three of the six tumours with abnormal karyotypes, and other changes of 6p and 14q in two of the remaining cases. Chromosomal arms 12q and 17p also appeared to be the sites of nonrandom recombination, being rearranged in three and two cases, respectively. When our findings in the present series are compared with previously (14)inv(14)(p13q24)t(6;14)(p21;q24).
reported chromosomal data on pulmonary hamartomas, the conclusion is strengthened that recombination of 6p2l and 14q24 is the primary karyotypic abnormality of these tumours: Fletcher et al. (1991) described a t(6;14) (p21;q24) in one of two hamartomas of the lung and we have described a t(3;6;14) (p21;p21;q24) as the sole aberration in another pulmonary hamartoma (Johansson et al., 1992) . Thus, of the nine karyotypically abnormal hamartomas of the lung available for evaluation, five have had rearrangements of 6p2l and 14q24 with translocations of the distal part of 6p to the der(14) or, less frequently, translocation of the distal part of 14q to the der(6). We suggest that the other rearrangements of 6p and 14q seen in pulmonary hamartomas constitute pathogenetically equivalent variants of the standard t(6;14). Non-pulmonary hamartomas, on the other hand, seem to have different karyotypic characteristics; the two liver hamartomas described by Speleman et al. (1989) and Mascarello & Krous (1992) There remains then the comparison with leiomyomas and chondromas, the benign mesenchymal tumours whose histogenetic features correspond to the dominant tissue elements in pulmonary hamartomas. Very little is known about the chromosome aberrations of chondromas, but what information there is indicates that the 12ql3-15 region is nonrandomly involved . This would then indicate some degree of similarity with pulmonary hamartoma karyotypes, in the sense that they too seem to have 12q rearrangements more often than chance would allow (Fletcher et al., 1991 ; cases 3-5 in Table I ).
The comparison between pulmonary hamartomas and leiomyoma is much easier, in as much as uterine leiomyomas are the benign tumours for which the most extensive cytogenetic data exists. The most characteristic karyotypic rearrangement in leiomyomas is t(12;14) (ql5;q24) (Heim et al., 1988; TurcCarel et al., 1988; Pandis et al., 1990) , i.e., a rearrangement affecting the same band in 14q that is also involved in the 6;14-translocation in hamartomas. Variant translocations are relatively common and mostly consist of rearrangements of 12q without visible recombination with 14q . Variant changes of 14q, but not of 12q, have been described in only five leiomyomas (Mugneret et al., 1988; Mark et al., 1990; Kiechle-Schwarz et al., 1991; Vanni et al., 1991) . It is remarkable, however, that 14q was recombined with 6p in two of these tumours, and in one of them an ins(l4;6)(q23;p23p25) was found as the only karyotypic anomaly. Finally, several cytogenetic subgroups of leiomyoma without 12q and 14q changes have also been described, tumours that seem to have evolved completely outside the t(12;14) pathway. The most numerous of these Figure 3 Representative karyogram from case 3. The rearrangements are der(l)ins(1;12)(p22p36;q24ql3) and t(6;17;13;14) (p21;pl2;ql4;q24). The four-way translocation leads to the formation of the following derivative chromosomes; der(6)t(6;14), del (13q), der(14)t(13;14), and der(17)t(6;17). Arrowheads indicate breakpoints. subsets are defined by the presence of trisomy 12, del(7q), and various rearrangements of 6p Pandis et al., 1991) .
The above collation of leiomyoma and hamartoma cytogenetics points to the frequent rearrangement of 14q24 as the main karyotypic similarity between the two tumours. The standard translocation in leiomyomas is t(12;14), with most variant translocations affecting 12q but not 14q. In contrast, the standard translocation in hamartomas of the lung seems to be t(6;14). Variants have been detected, involving both 6p and 14q, with no obvious frequency differences emerging until now. As far as chromosomes 6 and 12 are concerned, there seems to exist a sort of inverse parallelism: Involvement of 6p is a main feature of pulmonary hamartomas but is also relatively common in leiomyomas , whereas 12q changes predominate in leiomyomas but have also been seen repeatedly in the few hamartomas hitherto investigated.
Is the essential molecular outcome of t(6;14) in pulmonary hamartoma identical to that of t(12;14) in uterine leiomyoma? As long as the DNA-, RNA-, and protein-level results are not known for any of the translocations, the question cannot be satisfactorily answered. Even if the same gene in 14q24 were affected in leiomyomas and hamartomas, which we surmise but do not know, the variable translocation partners could nevertheless ensure that crucially different proteins are encoded, for instance if t(6;14) and t(12;14) both lead to the formation of fusion genes. This would offer a valid explanation for the phenotypic differences between the highly heterogeneous hamartomas and the monomorphic leiomyomas. It is not necessary to invoke molecular differences to explain the various histologies of the two tumour types, however; this could also be done by hypothesising that the tumourigenic events hit cells at different stages of pluripotentiality in different tumours. If the 14q24 gene recombines with a gene in 6p2l or 12q1 5 in a mesenchymal stem cell that is already committed to smooth muscle differentiation, then a leiomyoma results. When, on the other hand, the same event takes place in a more primitive mesenchymal stem cell in the airways, the clone emanating from this precursor cell may give rise to as diverse tissues as cartilage and smooth muscle fibers, with a hamartoma as the result. The cytogenetic findings are compatible with both scenarios, and regardless of which of them is more correct, the epithelial elements would not be part of the neoplastic parenchyma.
Having established that only the connective tissue cells are truly neoplastic in pulmonary hamartomas, one also needs to acknowledge the possibility -however remote it may seemthat only one of the dominant mesenchymal tissue components, not both, may constitute the neoplastic parenchyma. .: ..M"'-----..::..:"'':'',:,:'"',::""'','"',"",",'", :-."-. . 
